Michael Kramer, MD, PhD
Fourth Year Fellow
Washington University School of Medicine

Michael Kramer, MD, PhD

Fourth Year Fellow

Washington University School of Medicine

Title: Towards the identification of druggable targets for AML patients with DNMT3A and NPM1 mutations

No registration required.

Open to all faculty, staff, trainees and students.

CME credit available.

Please visit our website at: http://oncology.wustl.edu/